SEC Form 4 · accession 0001638599-17-000116
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lindsay A Rosenwald M.D.
Officer — President and CEO · Director · 10% Owner
Period of report
Dec 1, 2016
Accepted (ET)
Jan 27, 2017 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Dec 1, 2016 | P | 731 | $2.03 | A | 5,304,470 | D | |
| Common Stock, par value $0.001F2 | Jan 1, 2017 | A | 552,698 | $0.00 | A | 5,857,168 | D | |
| Common Stock, par value $0.001 | holding | — | — | — | 170,983 | I | By Capretti Grandi LLC | |
| Common Stock, par value $0.001 | holding | — | — | — | 453,822 | I | By LAR Family Trusts | |
| Common Stock, par value $0.001 | holding | — | — | — | 742,861 | I | By Paramount Biosciences | |
| Common Stock, par value $0.001 | holding | — | — | — | 100,000 | I | By The Lindsay A. Rosenwald Rhode Island Irrevocable Trust U/T/A DTD 8-28-01 | |
| Common Stock, par value $0.001 | holding | — | — | — | 80,000 | I | By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01 | |
| Common Stock, par value $0.001 | holding | — | — | — | 720,000 | I | By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00 | |
| Common Stock, par value $0.001 | holding | — | — | — | 100,000 | I | By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A DTD 8-29-01 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF3 | $1.37 | holding | — | — | — | — | Oct 5, 2020 | Common Stock | 25,000 | 25,000 | D |
| Options to purchase Common StockF4 | $6.25 | holding | — | — | — | — | Feb 10, 2022 | Common Stock | 15,000 | 15,000 | D |
| Options to purchase Common StockF5 | $7.42 | holding | — | — | — | — | Feb 7, 2023 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan.
- F2Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan.
- F3This option is fully vested.
- F4One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
- F5One-third of the shares vested on each of February 7, 2014, 2015 and 2016.